Viral vector-centric safety assessment of gene therapies; Updated and enhanced PubMed text mining data to complement curated safety alerts; Completion of the manual curation of the archive of PMDA drug approval packages.
Causality metadata & filter to identify treatment-related adverse events; Frequencies of adverse events; Safety data of vaccines approved by the FDA and EMA; Enhancement of the Secondary Pharmacology Panels tool.
New analytics page grouping the analytic tools by use case; New header, sub-header and search bar; Enhancement of the Drug Label Analyzer tool; Text mining results from FDA Summary Basis of Approval documents shown by default in all views.
Further integration of the RWE Analysis Dashboard in pharmacovigilance use cases; Shortcut to FDA Summary Basis of Approval documents; Expanded drug mapping between OFF-X and Cortellis Competitive Intelligence
Enhancement of the Safety Alerts section for the assessment of PV signals, including SMQ navigation and links to analytics; Enhanced SMQ navigation in the RWE Analysis Dashboard; Expansion of the retrospective coverage of FDA SBA documents.
Label changes and new adverse events notifications added to Keep Me Posted alerts; OFF-X Drug and Target/Class Score added to the Safety Alerts section; Enhanced filtering functionalities; Retrospective analysis of PMDA approval packages.
Further integration of safety data extracted from FDA Summary Basis of Approvals (SBA); Enhanced navigation of the FDA SBA text mining results; New filter in the RWE dashboard to exclude adverse events reported in FDA SBAs; Short-cut to the safety alerts of drug’s secondary targets; Seamless navigation between OFF-X and other Clarivate products.
Customization of the alerts sent to the user’s mailbox; New analytics to allow the comparison of the safety profile of drugs and their targets; Integration of safety data extracted from FDA Summary Basis of Approvals via text mining methods.
Usability enhancements with new filter options to quickly identify the adverse events of interest; Comparative Drug Safety Evidence and Master view heatmaps enhancements; FAERS and JADER content update.